Discover 1,088 paid clinical trials in Ogden, Utah. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,088
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
for
Acute Treatment of Migraine
Location: Salt Lake City UT, Aurora CO, Fresno CA, Scottsdale AZ,
Sponsor: Pfizer
Sex: All
Age: 6 - 17
Code: NCT04743141
Phase 3, Recruiting
New
Efficacy and Safety of VER-01 in the Treatment of Participants With Chronic Painful Lumbosacral Radiculopathy
for
Lumbosacral Radiculopathy
Location: Salt Lake City UT, Provo UT, Tempe AZ, Long Beach CA,
Sponsor: Vertanical GmbH
Sex: All
Age: 18+
Code: NCT06956014
Phase 3, Recruiting
A Phase 1 Study of ARC-001 in Participants Undergoing Third Molar Extraction
for
Acute Post Operative Pain, Third Molar Extraction Surgery
Location: Salt Lake City UT
Sponsor: Arcato Laboratories, Inc.
Sex: All
Age: 18 - 55
Code: NCT06864884
Early Phase 1, Recruiting
nCap Pain Relief Patch vs. Placebo
for
Osteoarthritis, Knee
Location: Salt Lake City UT
Sponsor: nCap Medical
Sex: All
Age: 40 - 70+
Code: NCT04753567
Recruiting
A Study to Evaluate Ibuprofen (IBU) 62.5 mg and Acetaminophen (APAP) 125 mg/5 ml in an Oral Liquid Suspension Fixed-Dose Combination Product in Children Aged 6 to 11 Years
for
Pain
Location: Salt Lake City UT
Sponsor: HALEON
Sex: All
Age: 6 - 11
Code: NCT07632274
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Sciatic Nerve Block With ALX006 in Subjects Undergoing Bunionectomy
for
Hallux Valgus, Bunionectomy
Location: Millcreek UT
Sponsor: Rebel Medicine Inc
Sex: All
Age: 18+
Code: NCT07574385
Phase 2, Recruiting
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
for
Chronic Kidney Disease and Hypertension
Location: South Salt Lake UT, Arvada CO, Surprise AZ, Concord CA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06742723
Phase 3, Recruiting
A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)
for
Metastatic Castration Resistant Prostate Cancer
Location: Murray UT, Fort Worth TX, Dallas TX, Houston TX,
Sponsor: ORIC Pharmaceuticals
Sex: Male
Age: 18+
Code: NCT07723248
Phase 3, Recruiting
Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
for
Type 2 Diabetes Mellitus, T2DM
Location: Salt Lake City UT, Las Vegas NV, Mesa AZ,
Sponsor: Hanmi Pharmaceutical Company Limited
Sex: All
Age: 18 - 70+
Code: NCT07527650
Phase 2, Recruiting
Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients
for
Migraine
Location: Salt Lake City UT, Las Vegas NV, Phoenix AZ,
Sponsor: Aspeya, Inc.
Sex: All
Age: 18 - 65
Code: NCT07646613
Phase 2, Recruiting
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
for
Type 2 Diabetes
Location: Salt Lake City UT, Blackfoot ID, Lincoln CA,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT07754461
Phase 3, Recruiting
A 52-Week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream in Adult Participants With Lichen Sclerosus
for
Lichen Sclerosus
Location: Murray UT, Scottsdale AZ, Phoenix AZ, Fremont CA,
Sponsor: LEO Pharma
Sex: All
Age: 18+
Code: NCT07335588
Phase 3, Recruiting
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
for
Uterine Fibroids, Endometriosis
Location: Salt Lake City UT, Pleasant Grove UT, Idaho Falls ID,
Sponsor: Sumitomo Pharma Switzerland GmbH
Sex: Female
Age: 18 - 50
Code: NCT05862272
Phase 3, Recruiting
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction